-
-
-
-
-
-
-
Royalty Pharma Agrees to Acquire Royalty Interest in Olpasiran From Arrowhead for $250 million and Future Milestones
-
-
-
-
-
-
-
Bragar Eagel & Squire is Investigating Certain Officers and Directors of comScore, Mammoth Energy, AMC Entertainment, and Arrowhead Pharmaceuticals and Encourages Investors to Contact the Firm
-
-
-
-
-
-
-
Arrowhead Pharmaceuticals Inc. (ARWR) Prices 4M Share Offering at $58/Sh
-
-
-
-
-
-
-
Pre-Open Movers 11/25: (SRNE) (MDCO) (TIF) Higher (CBAY) (UBER) (PRU) Lower (more...)
-
-
-
-
-
-
-
Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Marketplace Rule 5635(C)(4)
-
-
-
-
-
-
-
Amgen (AMGN), Arrowhead Pharmaceuticals (ARWR) Enter Collaborations on Two Cardiovascular Therapies
-
-
-
-
-
-
-
Arrowhead Reports Fiscal 2015 Second Quarter Financial Results
-
1,122,779 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

